C. Uehlinger

648 total citations
13 papers, 502 citations indexed

About

C. Uehlinger is a scholar working on Pharmacology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, C. Uehlinger has authored 13 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Epidemiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in C. Uehlinger's work include Substance Abuse Treatment and Outcomes (4 papers), Opioid Use Disorder Treatment (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). C. Uehlinger is often cited by papers focused on Substance Abuse Treatment and Outcomes (4 papers), Opioid Use Disorder Treatment (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). C. Uehlinger collaborates with scholars based in Switzerland and France. C. Uehlinger's co-authors include Pierre Baumann, Jean‐Jacques Déglon, Sylvie Petitjean, D Ladewig, Chin B. Eap, Rudolf Stohler, R. Nil, M. Amey, Dominique Baettig and Michèle Jonzier-Perey and has published in prestigious journals such as Drug and Alcohol Dependence, International Journal of Geriatric Psychiatry and Journal of Clinical Psychopharmacology.

In The Last Decade

C. Uehlinger

13 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Uehlinger Switzerland 8 207 199 142 142 120 13 502
I Arndt United States 9 172 0.8× 186 0.9× 144 1.0× 156 1.1× 61 0.5× 13 553
Gail Somer Canada 12 135 0.7× 123 0.6× 82 0.6× 94 0.7× 54 0.5× 19 658
D Ladewig Switzerland 17 281 1.4× 196 1.0× 128 0.9× 303 2.1× 114 0.9× 73 915
Elmer Yu United States 13 351 1.7× 204 1.0× 95 0.7× 299 2.1× 80 0.7× 18 820
Vishaal Mehra United States 6 132 0.6× 87 0.4× 67 0.5× 79 0.6× 55 0.5× 6 321
Judy M. Harrer United States 15 177 0.9× 127 0.6× 98 0.7× 236 1.7× 67 0.6× 16 865
Chieh-Liang Huang Taiwan 8 164 0.8× 86 0.4× 44 0.3× 47 0.3× 98 0.8× 14 523
Azmi Nasser United States 18 135 0.7× 136 0.7× 502 3.5× 39 0.3× 92 0.8× 36 731
John E. Peachey Canada 18 89 0.4× 74 0.4× 64 0.5× 175 1.2× 46 0.4× 36 695
William S. John United States 13 185 0.9× 121 0.6× 42 0.3× 186 1.3× 50 0.4× 25 565

Countries citing papers authored by C. Uehlinger

Since Specialization
Citations

This map shows the geographic impact of C. Uehlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Uehlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Uehlinger more than expected).

Fields of papers citing papers by C. Uehlinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Uehlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Uehlinger. The network helps show where C. Uehlinger may publish in the future.

Co-authorship network of co-authors of C. Uehlinger

This figure shows the co-authorship network connecting the top 25 collaborators of C. Uehlinger. A scholar is included among the top collaborators of C. Uehlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Uehlinger. C. Uehlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Uehlinger, C., et al.. (2007). Increased (R)-Methadone Plasma Concentrations by Quetiapine in Cytochrome P450s and ABCB1 Genotyped Patients. Journal of Clinical Psychopharmacology. 27(3). 273–278. 42 indexed citations
2.
Besson, Jacques, Marina Croquette-Krokar, Catherine Davidson, et al.. (2005). Prevalence of methadone injection in three Swiss cities. La Presse Médicale. 34(11). 776–780. 3 indexed citations
3.
Eap, Chin B., Christian C. Felder, Kerry Powell Golay, & C. Uehlinger. (2003). Increase of Oral Methadone Dose in Methadone Injecting Patients. Journal of Addictive Diseases. 22(3). 7–17. 6 indexed citations
4.
Petitjean, Sylvie, et al.. (2001). Double-blind randomized trial of buprenorphine and methadone in opiate dependence. Drug and Alcohol Dependence. 62(1). 97–104. 119 indexed citations
5.
Eap, Chin B., Franck Broly, Annie Mino, et al.. (2001). Cytochrome P450 2D6 Genotype and Methadone Steady-State Concentrations. Journal of Clinical Psychopharmacology. 21(2). 229–234. 91 indexed citations
6.
Felder, Christian C., C. Uehlinger, Pierre Baumann, Kerry Powell, & Chin B. Eap. (1999). Oral and intravenous methadone use: some clinical and pharmacokinetic aspects. Drug and Alcohol Dependence. 55(1-2). 137–143. 17 indexed citations
7.
Waldvogel, Daniel & C. Uehlinger. (1999). Zur Häufigkeit der Injektion von Methadon-Trinklösungen an einem Behandlungszentrum für Opiatabhängige. Fortschritte der Neurologie · Psychiatrie. 67(6). 281–283. 7 indexed citations
8.
Uehlinger, C., et al.. (1998). Comparison of Buprenorphine and Methadone in the Treatment of Opioid Dependence. European Addiction Research. 4(Suppl. 1). 13–18. 60 indexed citations
9.
Baumann, Pierre, R. Nil, Dominique Baettig, et al.. (1996). A Double-Blind, Placebo-Controlled Study of Citalopram With and Without Lithium in the Treatment of Therapy-Resistant Depressive Patients. Journal of Clinical Psychopharmacology. 16(4). 307–314. 132 indexed citations
10.
Uehlinger, C., R. Nil, M. Amey, Pierre Baumann, & H. Dufour. (1995). Citalopram‐lithium combination treatment of elderly depressed patients: A pilot study. International Journal of Geriatric Psychiatry. 10(4). 281–287. 13 indexed citations
11.
Uehlinger, C., et al.. (1992). Alopecia and mood stabilizers: Two case reports. European Archives of Psychiatry and Clinical Neuroscience. 242(2-3). 85–88. 8 indexed citations
12.
Uehlinger, C., Pierre Baumann, H. Dufour, & R. Nil. (1992). CITALOPRAM IN ELDERLY DEPRESSED PATIENTS AND ADJUNCTIVE LITHIUM IN NON-RESPONDERS. Clinical Neuropharmacology. 15. 339B–339B. 1 indexed citations
13.
Uehlinger, C., et al.. (1991). [Treatment of resistant depression with the citalopram-lithium combination. Methodology of a double-blind multicenter study and preliminary results].. PubMed. 17(3). 213–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I Arndt Breakdown of academic impact, for papers by Gail Somer Breakdown of academic impact, for papers by D Ladewig Breakdown of academic impact, for papers by Elmer Yu Breakdown of academic impact, for papers by Vishaal Mehra Breakdown of academic impact, for papers by Judy M. Harrer Breakdown of academic impact, for papers by Chieh-Liang Huang Breakdown of academic impact, for papers by Azmi Nasser Breakdown of academic impact, for papers by John E. Peachey Breakdown of academic impact, for papers by William S. John
Rankless by CCL
2026